We are live on ! Find out more
BIIB icon

Biogen
BIIB

916 hedge funds and large institutions have $25.1B invested in Biogen in 2024 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 270 increasing their positions, 378 reducing their positions, and 118 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.51% more ownership

Funds ownership: 88.6% → 89.11% (+0.51%)

3% less funds holding

Funds holding: 943 → 916 (-27)

16% less first-time investments, than exits

New positions opened: 99 | Existing positions closed: 118

16% less capital invested

Capital invested by funds: $29.9B → $25.1B (-$4.82B)

24% less call options, than puts

Call options by funds: $214M | Put options by funds: $282M

29% less repeat investments, than reductions

Existing positions increased: 270 | Existing positions reduced: 378

33% less funds holding in top 10

Funds holding in top 10: 12 → 8 (-4)

Holders
916
Holders Change
-27
Holders Change %
-2.86%
% of All Funds
13.15%
Holding in Top 10
8
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
99
Increased
270
Reduced
378
Closed
118
Calls
$214M
Puts
$282M
Net Calls
-$67.3M
Net Calls Change
-$32.9M

Top Buyers

1
BlackRock
BlackRock
New York
+$169M
2
Man Group
Man Group
United Kingdom
+$167M
3
JP Morgan Chase
JP Morgan Chase
New York
+$113M
4
Barclays
Barclays
United Kingdom
+$99.1M
5
Two Sigma Investments
Two Sigma Investments
New York
+$91.2M

Top Sellers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$298M
2
ClearBridge Investments
ClearBridge Investments
New York
-$181M
3
VanEck Associates
VanEck Associates
New York
-$172M
4
SCM
Sarissa Capital Management
Connecticut
-$129M
5
American Century Companies
American Century Companies
Missouri
-$126M
Name Holding Trade Value Shares
Change 		Change in
Stake
WSCM
951
Wellington Shields Capital Management
New York
– -$383K -1,652 Closed
WI
952
WrapManager Inc
California
– -$373K -1,611 Closed
SW
953
SVB Wealth
Massachusetts
– -$360K -1,552 Closed
MSAM
954
Moloney Securities Asset Management
Missouri
– -$356K -1,537 Closed
IA
955
IFG Advisory
Georgia
– -$350K -1,510 Closed
EWM
956
Empirical Wealth Management
Washington
– -$330K -1,422 Closed
WCM
957
Weik Capital Management
Pennsylvania
– -$313K -1,350 Closed
SCA
958
Snowden Capital Advisors
New York
– -$303K -1,307 Closed
EWS
959
Evergreen Wealth Solutions
Pennsylvania
– -$302K -1,302 Closed
SP
960
Symmetry Partners
Connecticut
– -$300K -1,293 Closed
MIS
961
Morningstar Investment Services
Illinois
– -$285K -1,245 Closed
DC
962
Davenport & Co
Virginia
– -$279K -1,205 Closed
FRA
963
Frank Rimerman Advisors
California
– -$273K -1,179 Closed
MW
964
Marcum Wealth
Ohio
– -$262K -1,131 Closed
ACM
965
Advisors Capital Management
New Jersey
– -$262K -1,130 Closed
TL
966
Tradewinds LLC
North Carolina
– -$261K -1,128 Closed
AWM
967
AE Wealth Management
Kansas
– -$259K -1,118 Closed
AAS
968
Avantax Advisory Services
Texas
– -$259K -1,117 Closed
MCM
969
MAI Capital Management
Ohio
– -$255K -1,102 Closed
TW
970
TritonPoint Wealth
Maryland
– -$246K -1,060 Closed
EIP
971
Epoch Investment Partners
New York
– -$245K -1,058 Closed
AFT
972
Alpha Family Trust
California
– -$243K -1,050 Closed
CFG
973
Citizens Financial Group
Rhode Island
– -$239K -1,033 Closed
MAC
974
Mason & Associates (California)
California
– -$238K -1,028 Closed
IWM
975
IHT Wealth Management
Illinois
– -$237K -1,021 Closed
37 38
39
40 41

BIIB Hedge Fund Activity: Q3 2024 in Review

916 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q3 2024, worth a combined $25.1B — down 16% from $29.9B a quarter earlier.

Sellers outnumbered buyers: 118 funds closed out of BIIB and 99 opened new positions — a net loss of 19 holders — while 378 trimmed existing stakes and 270 added.

The largest buyer was BlackRock, adding an estimated $169M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $298M.

  • 916 institutional investors held Biogen (BIIB) as of Q3 2024, down from 943 in Q2 2024.
  • Funds reported $25.1B of Biogen stock for Q3 2024, down 16% quarter-over-quarter.
  • 99 funds opened new Biogen positions in Q3 2024 and 118 closed out, a net change of -19 holders.
  • The largest Biogen buyer in Q3 2024 was BlackRock, an estimated $169M added.
  • The largest Biogen seller in Q3 2024 was T. Rowe Price Investment Management, an estimated $298M sold.

Based on aggregated 13F filings for Q3 2024.